Brief: Mymd Pharmaceuticals Advances Phase 2 Multi-Center Clinical Trial Of Mymd-1

Q/C Technologies

21/06/2022 18:57

June 21 (Reuters) - MyMD Pharmaceuticals Inc  MYMD.O :
    * MYMD PHARMACEUTICALS ADVANCES PHASE 2 MULTI-CENTER
CLINICAL
TRIAL OF MYMD-1 AS A THERAPY FOR DELAYING AGING AND EXTENDING
HEALTHY LIFESPAN
    * MYMD PHARMACEUTICALS INC- EFFICACY DATA EXPECTED IN SECOND
HALF
OF 2022

Source text for Eikon:  ID:nBw2yzq9La 
Further company coverage:  MYMD.O 

 ((Reuters.Briefs@thomsonreuters.com;))